Search

Thanks to everyone who voted last week on which day they'd like to receive Capsid & Tail! The results are: 71% Friday, 18% Monday, 6% Tuesday, 6% Thursday. So we'll be keeping our release date as-is, at least for now!

The next rendition of PHAVES will be a seminar with Rodrigo Ibarra Chavez on Oct 20 at 11AM Eastern / 5PM CEST. He'll tell us about phage-inducible chromosomal islands (PICIs), piracy in the phage-world, and insights on their application in

It was a great week for microbiology; Nobel prizes were awarded for discovering CRISPR-Cas (Emmanuelle Charpentier and Jennifer Doudna) and Hepatitis C (Harvey Alter, Michael Houghton, Charles Rice). The phage field should be especially pro

Saima Aslam (University of California, San Diego) and colleagues published a new paper in Open Forum Infectious Diseases showing the lessons the IPATH team has learned from their first 10 cases of IV phage therapy.

Sean Benler (NCBI) and colleagues published a new preprint on their identification of thousands of previously unknown phages in whole-community human gut metagenomes.

CARB-X is awarding the Indian phage biotech company GangaGen Biotechnologies up to $2.5 Million (with possibility of an additional $8.1 Million if milestones are met) to develop klebicins to treat Klebsiella pneumoniae.

All chapters of the recently-published textbook Bacteriophages: Biology, Technology, Therapy (edited by David Harper and colleagues) are now freely available online at this link.

Gabriella (Ella) Balasa, a cystic fibrosis (CF) patient who has received phage therapy, and her physician, Nauman Chaudary, have co-authored a unique perspective paper in Pulmonary Therapy about the experience and treatment of a CF patient.

Ruby Prosser Scully wrote a nice phage therapy article for the Australian healthcare professional-targeted paper Medical Republic. She interviews Australian phage researchers Peter Speck, Jon Iredell and Jeremy Barr, among others who are wo

The next rendition of PHAVES will be a seminar with Rodrigo Ibarra Chavez on Oct 20 at 11AM Eastern / 5PM CEST. He'll tell us about phage-inducible chromosomal islands (PICIs), piracy in the phage-world, and insights on their application in

Thanks so much to the nearly 300 people who attended the first iVoM webinar! The second iVoM event will be Thursday, October 15, 4PM GMT, and the theme will be "Virus structures and function". It will feature talks by: Petr Leiman, Univers

Thanks so much to the nearly 300 people who attended the first iVoM webinar! The second iVoM event will be Thursday, October 15, 4PM GMT, and the theme will be "Virus structures and function". It will feature talks by: Petr Leiman, Univers

Emily’s Entourage, a nonprofit organization that funds cystic fibrosis research and drug development, has funded four new grants (totaling $790,000 over two years), two of which are phage-related. One was awarded to IPATH researchers to dev

Locus Biosciences signed a $144 million contract with BARDA to support phase II and III clinical trials of LBP-EC01, Locus' CRISPR phage (crPhage™) product.

Adaptive Phage Therapeutics was recognized as a 2020 Champion of Maryland Manufacturing for its efforts to provide emergency phage access to COVID-19 patients with secondary bacterial infections.

Laith Harb (Texas A&M University) and colleagues published a new paper in PNAS showing that host cell penetration by the F-pilus-specific ssRNA phage MS2 triggers detachment of the F-pilus.

Luís Melo (University of Minho, Portugal) and colleagues published a detailed analysis of how the Staphylococcus epidermidis biofilm matrix protects against phage predation.

Xing Wan (KU Leuven and University of Helsinki) and colleagues published a new review in Current Opinion in Biotechnology on phage-based target discovery and its exploitation towards novel antibacterial molecules.

The Indian ‘Society for Bacteriophage Research and Therapy’ (SBRT) is a platform for phage researchers to share their expertise & resources. SBRT is pleased to announce a webinar on “Knowing the unknown: Approaches to characterize the vast

The next rendition of PHAVES will be a seminar/Q&A with Dr. Emma Bell, Principal Bacteriophage Scientist at FixedPhage, and will take place October 6th at 4PM GMT+1. She'll discuss their phage immobilization technology and how they've impro